How Many Times Can You Have TURBT For Bladder Cancer?

Medically reviewed by Mr Maneesh Ghei, Consultant Urological Surgeon (GMC: 5208045)

TURBT (transurethral resection of bladder tumour) is performed as often as necessary depending on the grade and stage of bladder cancer, the completeness of the initial resection, and whether surveillance cystoscopies show recurrence. For non-muscle-invasive bladder cancer (NMIBC), a second TURBT is often recommended within four to six weeks of the first if the initial resection was incomplete or the tumour was high-grade. Ongoing surveillance cystoscopies then detect recurrence, which may require further TURBT. There is no fixed maximum number of TURBTs, but repeated procedures increase the technical difficulty of future operations and overall treatment burden.

When Is A Second TURBT Needed?

A re-TURBT (second TURBT) is recommended in the following situations:

• High-grade (G3) non-muscle-invasive tumour even if the initial resection appeared complete, re-TURBT is standard because residual tumour is found in up to 45% of cases
• T1 tumour (lamina propria invasion) re-TURBT is particularly important to confirm the depth of invasion and exclude muscle involvement
• Incomplete initial resection if the surgeon was unable to fully resect the tumour in the first procedure
• No muscle in the specimen if no detrusor muscle was included in the resected tissue, re-TURBT is needed to ensure the staging is accurate

Re-TURBT is typically performed four to six weeks after the initial procedure, once the bladder has healed sufficiently.

How Often Do Bladder Cancer Patients Need TURBT?

After the initial TURBT (and re-TURBT if indicated), patients with non-muscle-invasive bladder cancer enter a surveillance programme. Cystoscopy is performed at regular intervals to check for recurrence. The frequency depends on risk stratification:

Low-risk tumours (single, small, low-grade, Ta): cystoscopy at 3 months, then annually for 5 years. Recurrence rate is lower, so TURBT may not be needed again if surveillance is clear.

Intermediate-risk tumours: cystoscopy at 3 months, 9 months, then annually. BCG or intravesical chemotherapy is often used to reduce recurrence between procedures.

High-risk tumours (high-grade, T1, carcinoma in situ): cystoscopy at 3 months, 6 months, then every 6 months for 2 years, then annually. These patients are at highest risk of recurrence and progression, and may require multiple TURBTs over time.

The British Association of Urological Surgeons (BAUS) guidance on bladder cancer sets out the surveillance protocols used in the UK.

Is There A Limit To How Many TURBTs Can Be Done?

There is no absolute limit to the number of TURBTs a patient can have. However, repeated procedures can cause complications that make future surgery more difficult, including:

• Bladder wall scarring (fibrosis), which can reduce bladder capacity over time
• Reduced visibility and access due to scar tissue
• Increased risk of bladder perforation with subsequent procedures
• Cumulative anaesthetic risk in older or frailer patients

For patients who experience very frequent recurrences despite adjuvant therapy, the urologist may discuss more radical options such as radical cystectomy (surgical removal of the bladder) or radical radiotherapy, particularly if the cancer is becoming resistant to treatment or if the burden of repeated surveillance and surgery is significantly affecting quality of life.

What Reduces The Need For Repeat TURBT?

Several adjuvant treatments are used to reduce the risk of bladder cancer recurring between TURBT procedures:

Intravesical BCG immunotherapy is the most effective adjuvant treatment for high-risk non-muscle-invasive bladder cancer. BCG is instilled directly into the bladder after TURBT and stimulates a local immune response that destroys residual tumour cells. A standard course involves induction (weekly for 6 weeks) followed by maintenance instillations over 1-3 years.

Intravesical chemotherapy such as mitomycin C is commonly used for intermediate-risk tumours. A single instillation immediately after TURBT reduces the risk of recurrence by flushing out tumour cells dislodged during surgery. Further courses may be given during surveillance.

Neither treatment replaces surveillance cystoscopy, but both can significantly reduce the frequency of TURBT needed over time.

Private TURBT And Bladder Cancer Follow-Up In London

If you have been diagnosed with bladder cancer and want expert private care for TURBT, surveillance, or a second opinion on your current treatment plan, Mr Maneesh Ghei offers private urology consultations at The Wellington Hospital, Platinum Medical Centre, St John’s Wood, London. He has extensive experience in the management of bladder cancer including TURBT, BCG therapy, and long-term surveillance. Same-week appointments are available and no GP referral is required.

Frequently Asked Questions

How many times can you have a TURBT?

There is no fixed limit. TURBT is performed whenever surveillance cystoscopy detects a recurrence that requires treatment. Multiple TURBTs over many years are common in patients with non-muscle-invasive bladder cancer. However, repeated procedures can cause bladder scarring over time, and patients with very frequent recurrences may be offered more radical treatment options.

Why is a second TURBT recommended after the first?

A second TURBT within 4 to 6 weeks of the first is recommended for high-grade tumours or T1 disease because residual tumour is found in a significant proportion of cases even when the initial resection appeared complete. It also confirms the depth of invasion and ensures accurate staging before deciding on adjuvant treatment.

How often do you need surveillance cystoscopy after TURBT?

The frequency depends on tumour risk. Low-risk patients have cystoscopy at 3 months then annually. High-risk patients have cystoscopy at 3 months, 6 months, then every 6 months for 2 years, then annually. Surveillance continues lifelong because bladder cancer has a high recurrence rate even years after initial treatment.

Does TURBT cure bladder cancer?

TURBT can cure non-muscle-invasive bladder cancer when combined with appropriate adjuvant therapy and surveillance. However, the underlying tendency of the bladder lining to develop new tumours is not cured. Regular lifelong cystoscopy is required, and further TURBTs may be needed for recurrences. Muscle-invasive bladder cancer is not cured by TURBT alone and requires more radical treatment.

What happens if bladder cancer keeps coming back after TURBT?

If bladder cancer recurs frequently despite adjuvant therapy with BCG or intravesical chemotherapy, the urologist will review the treatment plan. Options may include intensified BCG therapy, alternative intravesical treatments, clinical trials, or discussion of more radical options such as cystectomy (bladder removal) or radical radiotherapy, particularly if tumour grade or stage is increasing.

Where can I get a private consultation about TURBT in London?

Mr Maneesh Ghei is a consultant urological surgeon based at The Wellington Hospital, Platinum Medical Centre, St John’s Wood, London NW8 7JA. He specialises in bladder cancer management including TURBT, BCG therapy, and surveillance programmes. Same-week appointments are available with no GP referral required. Both self-funded and insured patients are welcome.

About the Author

Mr Maneesh Ghei, Consultant Urological Surgeon (GMC: 5208045)

Mr Maneesh Ghei is a consultant urological surgeon with NHS and private practice across four London hospitals. He has extensive experience in the management of bladder cancer including TURBT, BCG immunotherapy, intravesical chemotherapy, and long-term cystoscopic surveillance. Mr Ghei sees new patients privately with same-week availability. No GP referral is required. Book a private urology consultation.